Skip to content

LDA registrant 401105735

DENDREON PHARMACEUTICALS, LLC

Open official API record

Source-supplied identity

Registrant details

Exact LDA ID: 401105735
State: CA
Country: US
House registrant ID: 44876

biopharmaceutical company that manufactures an immunotherapy for prostate cancer

Exact source ID relationship

Recent filings

6 total

DENDREON PHARMACEUTICALS, LLCDENDREON PHARMACEUTICALS, LLC · 2nd Quarter (Apr 1 - June 30) 2026
Sep 9, 2026
DENDREON PHARMACEUTICALS, LLCDENDREON PHARMACEUTICALS, LLC · 1st Quarter (Jan 1 - Mar 31) 2026
May 26, 2026
DENDREON PHARMACEUTICALS, LLCDENDREON PHARMACEUTICALS, LLC · 4th Quarter (Oct 1 - Dec 31) 2025
Feb 25, 2026
DENDREON PHARMACEUTICALS, LLCDENDREON PHARMACEUTICALS, LLC · 3rd Quarter (July 1 - Sep 30) 2025
Dec 3, 2025
DENDREON PHARMACEUTICALS, LLCDENDREON PHARMACEUTICALS, LLC · 2nd Quarter (Apr 1 - June 30) 2025
Aug 19, 2025
DENDREON PHARMACEUTICALS, LLCDENDREON PHARMACEUTICALS, LLC · 1st Quarter (Jan 1 - Mar 31) 2025
May 6, 2025

Identity boundary

This page groups filings only by the exact numeric identifier supplied by the LDA API. Politically.com does not merge similar names or infer organizational relationships.